{
  "completed_form": {
    "Precertification Request Details": {
      "Request Type": "Start of treatment",
      "Start date": "2024-05-22",
      "Date of last treatment": null,
      "Precertification Requested By Name": "Erfan Rostami, BSN, RN",
      "Precertification Requested By Phone": "615-343-1176",
      "Precertification Requested By Fax": "615-343-1219"
    },
    "Patient Information": {
      "First Name": "Shakh",
      "Last Name": "Abdulla",
      "DOB": "2001-04-01",
      "Address": "425 Sherman Aves AP'T D",
      "City": "Nashville",
      "State": "TN",
      "ZIP": null,
      "Home Phone": "865-395-3958",
      "Work Phone": null,
      "Cell Phone": "865-395-0481",
      "E-mail": null,
      "Current Weight": null,
      "Height": null,
      "Allergies": "No Known Allergies"
    },
    "Insurance Information": {
      "Member ID #": "LAJM14345116",
      "Does patient have other coverage?": false,
      "Group #": "435000",
      "Other Coverage ID #": null,
      "Other Coverage Carrier Name": null,
      "Insured 1": "ABDULLA, SHAKH",
      "Insured 2": null,
      "Insured 3": null
    },
    "Prescriber Information": {
      "First Name": "Hao",
      "Last Name": "Gu",
      "Prescriber Type": "M.D.",
      "Address": "3320 Montgomery Dr",
      "City": "Nashville",
      "State": "TN",
      "ZIP": "37361",
      "Phone": "614-936-0065",
      "Fax": null,
      "St Lic #": null,
      "NPI #": "1154611523",
      "DEA #": null,
      "UPIN": null,
      "Provider Email": null,
      "Office Contact Name": null,
      "Office Contact Phone": null
    },
    "Dispensing Provider/Administration Information": {
      "Place of Administration": "Outpatient Infusion Center",
      "Dispensing Provider/Pharmacy Type": null,
      "Dispensing Provider/Pharmacy Name": null,
      "Dispensing Provider/Pharmacy Phone": null,
      "Dispensing Provider/Pharmacy Fax": null,
      "Dispensing Provider/Pharmacy Other Type Description": null,
      "Administration code(s) (CPT)": null,
      "Agency Name": null,
      "Agency Contact Name": null,
      "Agency Address": null,
      "Agency City": null,
      "Agency State": null,
      "Agency ZIP": null,
      "Agency Phone": null,
      "Agency Fax": null,
      "Agency TIN": null,
      "Agency PIN": null,
      "Agency NPI 1": null,
      "Agency NPI 2": null
    },
    "Product Information": {
      "Request is for": "Truxima (rituximab-abbs)",
      "Dose": "694 mg",
      "Directions for Use": "Initial dose: Every 2 weeks; Maintenance dose: Every 24 weeks",
      "HCPCS Code": null
    },
    "Diagnosis Information": {
      "Primary ICD Code": "G35",
      "Other ICD Code": null
    },
    "Clinical Information": {
      "Has the patient had prior therapy with the requested product within the last 365 days?": false,
      "Has the patient had a trial and failure of any of the following rituximab biosimilars?": false,
      "Rituximab Biosimilars Tried and Failed": null,
      "When was the member's trial and failure of the preferred drug?": null,
      "Please describe the nature of the failure of the preferred drug": null,
      "Has the patient had an adverse reaction to any of the following rituximab biosimilars?": false,
      "Rituximab Biosimilars with Adverse Reaction": null,
      "When was the member's adverse reaction to the preferred drug?": null,
      "Please describe the nature of the adverse reaction to the preferred drug": null,
      "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient's diagnosis?": null,
      "Has the patient had a trial and failure of any of the following? (MA plans)": false,
      "MA Plan Preferred Drugs Tried and Failed": null,
      "When was the member's trial and failure of the preferred drug? (MA plans)": null,
      "Please describe the nature of the failure of the preferred drug (MA plans)": null,
      "Has the patient had an adverse reaction to any of the following? (MA plans)": false,
      "MA Plan Preferred Drugs with Adverse Reaction": null,
      "When was the member's adverse reaction to the preferred drug? (MA plans)": null,
      "Please describe the nature of the adverse reaction to the preferred drug (MA plans)": null,
      "Has the patient had a trial and failure of any of the following? (MAPD plans)": false,
      "MAPD Plan Preferred Drugs Tried and Failed": null,
      "When was the member's trial and failure of the preferred drug? (MAPD plans)": null,
      "Please describe the nature of the failure of the preferred drug (MAPD plans)": null,
      "Has the patient had a trial and failure of any of the following? (MAPD plans, set 2)": false,
      "MAPD Plan Preferred Drugs with Adverse Reaction (due to form inconsistency)": null,
      "When was the member's adverse reaction to the preferred drug? (MAPD plans)": null,
      "Please describe the nature of the adverse reaction to the preferred drug? (MAPD plans)": null,
      "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient's diagnosis? (MA plans)": null,
      "Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient's diagnosis? (MAPD plans)": null,
      "Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs (e.g., adalimumab, infliximab)?": false,
      "Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?": false,
      "Is Rituxan (rituximab) being used as induction/consolidation therapy? (ALL)": null,
      "Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?": false,
      "ANCA-associated vasculitides type": null,
      "Will Rituxan (rituximab) be given in conjunction with glucocorticoids? (ANCA)": true,
      "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?": false,
      "Autoimmune blistering disease type": null,
      "B-cell lymphoma type": null,
      "B-cell lymphoma Other type description": null,
      "Does the patient have a documented diagnosis of multicentric Castleman's disease (angiofollicular lymph node hyperplasia)?": false,
      "Central nervous system lymphoma type": null,
      "Chronic or small lymphocytic leukemia type": null,
      "Does the patient have a documented diagnosis of cryoglobulinemia?": false,
      "Is there clinical documentation that the treatment with corticosteroids and other immunosuppressive agents was ineffective? (Cryoglobulinemia)": null,
      "Is there a documentation that Rituxan (rituximab) being used as last-resort treatment for chronic graft versus host disease (GVHD)?": false,
      "Hairy cell leukemia type": null,
      "Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients?": false,
      "Transplant recipient type": null,
      "Immune checkpoint-inhibitor caused encephalitis type": null,
      "Immune checkpoint-inhibitor caused encephalitis Other type description": null,
      "Severity of the patient's rheumatoid arthritis": null,
      "Is there evidence that the disease is active? (Rheumatoid Arthritis)": null,
      "Will Rituxan (rituximab) be used in combination with methotrexate? (Rheumatoid Arthritis)": null,
      "Was treatment with methotrexate ineffective, not tolerated or contraindicated?": null,
      "Methotrexate treatment reason for non-use": null,
      "Was treatment with another conventional DMARD ineffective?": null,
      "Conventional DMARDs tried": null,
      "Does the patient have a documented diagnosis of Sj\u00f6gren's syndrome?": false,
      "Was treatment with corticosteroids and other immunosuppressive agents ineffective? (Sj\u00f6gren syndrome)": null,
      "Medication 1 used (Sj\u00f6gren syndrome)": null,
      "Dates 1 used (Sj\u00f6gren syndrome)": null,
      "Medication 2 used (Sj\u00f6gren syndrome)": null,
      "Dates 2 used (Sj\u00f6gren syndrome)": null,
      "Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?": false,
      "Does the patient have a documented diagnosis of Waldenstr\u00f6m macroglobulinemia?": false,
      "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?": false,
      "Length of time on Rituxan (rituximab)": null
    }
  },
  "processing_notes": [
    {
      "field": "Date of last treatment",
      "note": "Dependent field's condition ('Request Type' = 'Continuation of therapy') was not met."
    },
    {
      "field": "ZIP",
      "note": "Conflicting information for patient's ZIP code found (37995 vs 37923). Set to null due to ambiguity."
    },
    {
      "field": "Work Phone",
      "note": "Information not found in source text."
    },
    {
      "field": "E-mail",
      "note": "Information not found in source text."
    },
    {
      "field": "Current Weight",
      "note": "Information not found in source text."
    },
    {
      "field": "Height",
      "note": "Information not found in source text."
    },
    {
      "field": "Other Coverage ID #",
      "note": "Dependent field's condition ('Does patient have other coverage?' = 'true') was not met."
    },
    {
      "field": "Other Coverage Carrier Name",
      "note": "Dependent field's condition ('Does patient have other coverage?' = 'true') was not met."
    },
    {
      "field": "Insured 2",
      "note": "Information not found in source text."
    },
    {
      "field": "Insured 3",
      "note": "Information not found in source text."
    },
    {
      "field": "Fax",
      "note": "Specific fax number for the prescriber (Dr. Gu) not found, only general center fax."
    },
    {
      "field": "St Lic #",
      "note": "Information not found in source text."
    },
    {
      "field": "DEA #",
      "note": "Information not found in source text."
    },
    {
      "field": "UPIN",
      "note": "Information not found in source text."
    },
    {
      "field": "Provider Email",
      "note": "Information not found in source text."
    },
    {
      "field": "Office Contact Name",
      "note": "Information not found in source text."
    },
    {
      "field": "Office Contact Phone",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy Type",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy Name",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy Phone",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy Fax",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy Other Type Description",
      "note": "Dependent field's condition ('Dispensing Provider/Pharmacy Type' = 'Other') was not met."
    },
    {
      "field": "Administration code(s) (CPT)",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency Name",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency Contact Name",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency Address",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency City",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency State",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency ZIP",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency Phone",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency Fax",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency TIN",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency PIN",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency NPI 1",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency NPI 2",
      "note": "Information not found in source text."
    },
    {
      "field": "HCPCS Code",
      "note": "Information not found in source text."
    },
    {
      "field": "Other ICD Code",
      "note": "Information not found in source text."
    },
    {
      "field": "Rituximab Biosimilars Tried and Failed",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "When was the member's trial and failure of the preferred drug?",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "Please describe the nature of the failure of the preferred drug",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "Rituximab Biosimilars with Adverse Reaction",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "When was the member's adverse reaction to the preferred drug?",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "Please describe the nature of the adverse reaction to the preferred drug",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient's diagnosis?",
      "note": "Information not found or clearly implied in source text."
    },
    {
      "field": "MA Plan Preferred Drugs Tried and Failed",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MA plans)' = 'true') was not met."
    },
    {
      "field": "When was the member's trial and failure of the preferred drug? (MA plans)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MA plans)' = 'true') was not met."
    },
    {
      "field": "Please describe the nature of the failure of the preferred drug (MA plans)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MA plans)' = 'true') was not met."
    },
    {
      "field": "MA Plan Preferred Drugs with Adverse Reaction",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following? (MA plans)' = 'true') was not met."
    },
    {
      "field": "When was the member's adverse reaction to the preferred drug? (MA plans)",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following? (MA plans)' = 'true') was not met."
    },
    {
      "field": "Please describe the nature of the adverse reaction to the preferred drug (MA plans)",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following? (MA plans)' = 'true') was not met."
    },
    {
      "field": "MAPD Plan Preferred Drugs Tried and Failed",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MAPD plans)' = 'true') was not met."
    },
    {
      "field": "When was the member's trial and failure of the preferred drug? (MAPD plans)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MAPD plans)' = 'true') was not met."
    },
    {
      "field": "Please describe the nature of the failure of the preferred drug (MAPD plans)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MAPD plans)' = 'true') was not met."
    },
    {
      "field": "MAPD Plan Preferred Drugs with Adverse Reaction (due to form inconsistency)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MAPD plans, set 2)' = 'true') was not met."
    },
    {
      "field": "When was the member's adverse reaction to the preferred drug? (MAPD plans)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MAPD plans, set 2)' = 'true') was not met."
    },
    {
      "field": "Please describe the nature of the adverse reaction to the preferred drug? (MAPD plans)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following? (MAPD plans, set 2)' = 'true') was not met."
    },
    {
      "field": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient's diagnosis? (MA plans)",
      "note": "Information not found or clearly implied in source text."
    },
    {
      "field": "Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient's diagnosis? (MAPD plans)",
      "note": "Information not found or clearly implied in source text."
    },
    {
      "field": "Is Rituxan (rituximab) being used as induction/consolidation therapy? (ALL)",
      "note": "Dependent field's condition ('Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?' = 'true') was not met."
    },
    {
      "field": "ANCA-associated vasculitides type",
      "note": "Information not found in source text."
    },
    {
      "field": "Autoimmune blistering disease type",
      "note": "Dependent field's condition ('Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?' = 'true') was not met."
    },
    {
      "field": "B-cell lymphoma type",
      "note": "Information not found in source text."
    },
    {
      "field": "B-cell lymphoma Other type description",
      "note": "Dependent field's condition ('B-cell lymphoma type' = 'Other') was not met."
    },
    {
      "field": "Central nervous system lymphoma type",
      "note": "Information not found in source text."
    },
    {
      "field": "Chronic or small lymphocytic leukemia type",
      "note": "Information not found in source text."
    },
    {
      "field": "Is there clinical documentation that the treatment with corticosteroids and other immunosuppressive agents was ineffective? (Cryoglobulinemia)",
      "note": "Dependent field's condition ('Does the patient have a documented diagnosis of cryoglobulinemia?' = 'true') was not met."
    },
    {
      "field": "Hairy cell leukemia type",
      "note": "Information not found in source text."
    },
    {
      "field": "Transplant recipient type",
      "note": "Dependent field's condition ('Is there a documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with antibody mediated rejection in heart transplant recipients and other solid organ transplant recipients?' = 'true') was not met."
    },
    {
      "field": "Immune checkpoint-inhibitor caused encephalitis type",
      "note": "Information not found in source text."
    },
    {
      "field": "Immune checkpoint-inhibitor caused encephalitis Other type description",
      "note": "Dependent field's condition ('Immune checkpoint-inhibitor caused encephalitis type' = 'Other') was not met."
    },
    {
      "field": "Severity of the patient's rheumatoid arthritis",
      "note": "Patient's diagnosis is Multiple Sclerosis, not Rheumatoid Arthritis. Field not applicable."
    },
    {
      "field": "Is there evidence that the disease is active? (Rheumatoid Arthritis)",
      "note": "Patient's diagnosis is Multiple Sclerosis, not Rheumatoid Arthritis. Field not applicable."
    },
    {
      "field": "Will Rituxan (rituximab) be used in combination with methotrexate? (Rheumatoid Arthritis)",
      "note": "Patient's diagnosis is Multiple Sclerosis, not Rheumatoid Arthritis. Field not applicable."
    },
    {
      "field": "Was treatment with methotrexate ineffective, not tolerated or contraindicated?",
      "note": "Patient's diagnosis is Multiple Sclerosis, not Rheumatoid Arthritis. Field not applicable."
    },
    {
      "field": "Methotrexate treatment reason for non-use",
      "note": "Dependent field's condition ('Was treatment with methotrexate ineffective, not tolerated or contraindicated?' = 'true') was not met."
    },
    {
      "field": "Was treatment with another conventional DMARD ineffective?",
      "note": "Patient's diagnosis is Multiple Sclerosis, not Rheumatoid Arthritis. Field not applicable."
    },
    {
      "field": "Conventional DMARDs tried",
      "note": "Dependent field's condition ('Was treatment with another conventional DMARD ineffective?' = 'true') was not met."
    },
    {
      "field": "Was treatment with corticosteroids and other immunosuppressive agents ineffective? (Sj\u00f6gren syndrome)",
      "note": "Dependent field's condition ('Does the patient have a documented diagnosis of Sj\u00f6gren's syndrome?' = 'true') was not met."
    },
    {
      "field": "Medication 1 used (Sj\u00f6gren syndrome)",
      "note": "Dependent field's condition ('Was treatment with corticosteroids and other immunosuppressive agents ineffective? (Sj\u00f6gren syndrome)' = 'true') was not met."
    },
    {
      "field": "Dates 1 used (Sj\u00f6gren syndrome)",
      "note": "Dependent field's condition ('Was treatment with corticosteroids and other immunosuppressive agents ineffective? (Sj\u00f6gren syndrome)' = 'true') was not met."
    },
    {
      "field": "Medication 2 used (Sj\u00f6gren syndrome)",
      "note": "Dependent field's condition ('Was treatment with corticosteroids and other immunosuppressive agents ineffective? (Sj\u00f6gren syndrome)' = 'true') was not met."
    },
    {
      "field": "Dates 2 used (Sj\u00f6gren syndrome)",
      "note": "Dependent field's condition ('Was treatment with corticosteroids and other immunosuppressive agents ineffective? (Sj\u00f6gren syndrome)' = 'true') was not met."
    },
    {
      "field": "Length of time on Rituxan (rituximab)",
      "note": "Patient is starting therapy; no length of time on medication prior to this request."
    }
  ]
}